We are live on
!
Find out more
Travere Therapeutics
TVTX
TVTX
138 hedge funds and large institutions have $1.42B invested in Travere Therapeutics in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 41 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.22% more ownership
Funds ownership: 102.24% → 102.46% (+0.22%)
22% less call options, than puts
Call options by funds: $3.51M | Put options by funds: $4.49M
Holders
138
Holding in Top 10
1
Calls
$3.51M
Puts
$4.49M
Top Buyers
| 1 | +$30.7M | |
| 2 | +$23M | |
| 3 | +$11.1M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$11.1M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$9.96M |
Top Sellers
| 1 | -$35.5M | |
| 2 | -$13.8M | |
| 3 | -$11.1M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$10.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.82M |